Biomarker Discovery in Identifying At-Risk Metabolic Dysfunction-Associated Steatohepatitis Patients: A Bench Overview

Description

In this scientific session, experts educate attendees regarding the application of various omics technologies in the diagnosis and staging of metabolic dysfunction-associated steatohepatitis (MASH). Presenters focus on metabolomics, covering principles, biomarkers, and research techniques. Experts also dive into proteomics, exploring protein profiles and methodologies. Faculty highlight the role of microRNA and extracellular vesicles, emphasizing their significance and research methods. The session aims to impart insights into how these omics approaches contribute to a better understanding of MASH diagnosis and staging.